The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Varicella Vaccine Market Research Report 2025
Synopsis
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
The global Varicella Vaccine market was valued at US$ 4174 million in 2023 and is anticipated to reach US$ 7104.7 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
This report aims to provide a comprehensive presentation of the global market for Varicella Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varicella Vaccine.
Report Scope
The Varicella Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Varicella Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varicella Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Segment by Type
Injection
Freeze-Dried Powder
Segment by Application
Kids Injection
Adults Injection
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Varicella Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
The global Varicella Vaccine market was valued at US$ 4174 million in 2023 and is anticipated to reach US$ 7104.7 million by 2030, witnessing a CAGR of 7.8% during the forecast period 2024-2030.
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
This report aims to provide a comprehensive presentation of the global market for Varicella Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varicella Vaccine.
Report Scope
The Varicella Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Varicella Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varicella Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Segment by Type
Injection
Freeze-Dried Powder
Segment by Application
Kids Injection
Adults Injection
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Varicella Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Varicella Vaccine Market Overview
1.1 Product Overview and Scope of Varicella Vaccine
1.2 Varicella Vaccine Segment by Type
1.2.1 Global Varicella Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Varicella Vaccine Segment by Application
1.3.1 Global Varicella Vaccine Market Value by Application: (2024-2030)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Global Varicella Vaccine Market Size Estimates and Forecasts
1.4.1 Global Varicella Vaccine Revenue 2019-2030
1.4.2 Global Varicella Vaccine Sales 2019-2030
1.4.3 Global Varicella Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Varicella Vaccine Market Competition by Manufacturers
2.1 Global Varicella Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Varicella Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Varicella Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Varicella Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Varicella Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Varicella Vaccine, Product Type & Application
2.7 Varicella Vaccine Market Competitive Situation and Trends
2.7.1 Varicella Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Varicella Vaccine Players Market Share by Revenue
2.7.3 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Varicella Vaccine Retrospective Market Scenario by Region
3.1 Global Varicella Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Varicella Vaccine Global Varicella Vaccine Sales by Region: 2019-2030
3.2.1 Global Varicella Vaccine Sales by Region: 2019-2024
3.2.2 Global Varicella Vaccine Sales by Region: 2025-2030
3.3 Global Varicella Vaccine Global Varicella Vaccine Revenue by Region: 2019-2030
3.3.1 Global Varicella Vaccine Revenue by Region: 2019-2024
3.3.2 Global Varicella Vaccine Revenue by Region: 2025-2030
3.4 North America Varicella Vaccine Market Facts & Figures by Country
3.4.1 North America Varicella Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Varicella Vaccine Sales by Country (2019-2030)
3.4.3 North America Varicella Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Varicella Vaccine Market Facts & Figures by Country
3.5.1 Europe Varicella Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Varicella Vaccine Sales by Country (2019-2030)
3.5.3 Europe Varicella Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Varicella Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Varicella Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Varicella Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Varicella Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Varicella Vaccine Market Facts & Figures by Country
3.7.1 Latin America Varicella Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Varicella Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Varicella Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Varicella Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Varicella Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Varicella Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Varicella Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Varicella Vaccine Sales by Type (2019-2030)
4.1.1 Global Varicella Vaccine Sales by Type (2019-2024)
4.1.2 Global Varicella Vaccine Sales by Type (2025-2030)
4.1.3 Global Varicella Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Varicella Vaccine Revenue by Type (2019-2030)
4.2.1 Global Varicella Vaccine Revenue by Type (2019-2024)
4.2.2 Global Varicella Vaccine Revenue by Type (2025-2030)
4.2.3 Global Varicella Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Varicella Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Varicella Vaccine Sales by Application (2019-2030)
5.1.1 Global Varicella Vaccine Sales by Application (2019-2024)
5.1.2 Global Varicella Vaccine Sales by Application (2025-2030)
5.1.3 Global Varicella Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Varicella Vaccine Revenue by Application (2019-2030)
5.2.1 Global Varicella Vaccine Revenue by Application (2019-2024)
5.2.2 Global Varicella Vaccine Revenue by Application (2025-2030)
5.2.3 Global Varicella Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Varicella Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Varicella Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Varicella Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Shanghai Institute
6.3.1 Shanghai Institute Corporation Information
6.3.2 Shanghai Institute Description and Business Overview
6.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shanghai Institute Varicella Vaccine Product Portfolio
6.3.5 Shanghai Institute Recent Developments/Updates
6.4 BCHT
6.4.1 BCHT Corporation Information
6.4.2 BCHT Description and Business Overview
6.4.3 BCHT Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BCHT Varicella Vaccine Product Portfolio
6.4.5 BCHT Recent Developments/Updates
6.5 Changsheng
6.5.1 Changsheng Corporation Information
6.5.2 Changsheng Description and Business Overview
6.5.3 Changsheng Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Changsheng Varicella Vaccine Product Portfolio
6.5.5 Changsheng Recent Developments/Updates
6.6 Keygen
6.6.1 Keygen Corporation Information
6.6.2 Keygen Description and Business Overview
6.6.3 Keygen Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Keygen Varicella Vaccine Product Portfolio
6.6.5 Keygen Recent Developments/Updates
6.7 Green Cross
6.6.1 Green Cross Corporation Information
6.6.2 Green Cross Description and Business Overview
6.6.3 Green Cross Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Green Cross Varicella Vaccine Product Portfolio
6.7.5 Green Cross Recent Developments/Updates
6.8 Biken
6.8.1 Biken Corporation Information
6.8.2 Biken Description and Business Overview
6.8.3 Biken Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biken Varicella Vaccine Product Portfolio
6.8.5 Biken Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Varicella Vaccine Industry Chain Analysis
7.2 Varicella Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Varicella Vaccine Production Mode & Process
7.4 Varicella Vaccine Sales and Marketing
7.4.1 Varicella Vaccine Sales Channels
7.4.2 Varicella Vaccine Distributors
7.5 Varicella Vaccine Customers
8 Varicella Vaccine Market Dynamics
8.1 Varicella Vaccine Industry Trends
8.2 Varicella Vaccine Market Drivers
8.3 Varicella Vaccine Market Challenges
8.4 Varicella Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
